Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment.

Cheng Kong,Shaorong Yu,Pudong Qian,Xue Song, Jing Wen,Ming Jiang,Jun Zhu,Jianhua Xu,Lijun Zhao, Zhen Guo,Jianfeng Wu,Xia He,Xiangzhi Zhu

Frontiers in oncology（2023）

引用 0|浏览3

暂无评分

摘要

WBRT plus anlotinib, as a convenient chemo-free regimen, may represent an overall safe and effective procedure in advanced NSCLC with multiple BMs that progressed or developed after standard systematic treatment.

查看译文

关键词

non-small cell lung cancer, brain metastases, later-line, whole-brain radiotherapy, antiangiogenic TKIs

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要